FDA.reportPublic FDA data

BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4%

Manufacturer
Sincerus Florida, LLC
Effective date
2019-05-20
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:28:52

Label at a glance#

ProductBETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4%
Active ingredientBETAMETHASONE DIPROPIONATE, NIACINAMIDE
Label structure4 sections

Label contents#

Full prescribing information#

Directions for use. As directed by Physician. Apply topically. For external use only. Wash hands after use. Store at controlled room temperature 20-25 Celsius.

INSTRUCTIONS FOR USE SECTION

fsfs

Sincerus Florida, LLC. Adverse reactions

ADVERSE REACTIONS SECTION

dfdf

Active, inactive

COMPONENTS

wrwr

NDC 72934- 2026-2 BETAMETHASONE DIPROPIONATE USP 0.05% / NIACINAMIDE USP 4% Cream 30 gm.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

sfsf

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BETAMETHASONE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dde7b902-54a1-627e-12f1-9e6d244ab88cProduct name420250317
69b49899-11cf-4f7e-bd0a-7dc93b27311bProduct name320250130
bbdc14c7-d940-43b5-a2f7-36c425991f3cProduct name120240320
0a2fcc35-464b-9ec2-a622-753662cdd48cProduct name320240216
6f762601-17ef-4321-8f47-77783d3c4d8bProduct name320231116
1dbefad7-ab34-69c3-e51a-e7148aa38f70Product name520220921
7fea2046-07a9-4bb6-9409-828ac6f1f6dfProduct name120210201
f059f1a2-0e64-4839-9a7f-42687c91a44bProduct name120201007
4ea9e4b5-b452-48ad-9b25-b9a4d403405dProduct name120160310
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
4f07db9b-3707-3e2c-05b5-d7852ba808c4Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72934-2026-22021-01-29C16284748780-1ba0f9c33-118e-a910-e053-dadaa90a0b85BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72934-2026-2BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4%30 g in 1 BOTTLE, PUMPCREAM301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72934-2026BETAMETHASONE DIPROPIONATE 0.05% / NIACINAMIDE 4% CREAM [SINCERUS FLORIDA, LLC]1Legacy NDC, 1 package rows20190521_89569a9d-d53d-f72d-e053-2a95a90aa9b9.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72934-202672934-2026-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
BETAMETHASONE DIPROPIONATE826Y60901UACTIM
NIACINAMIDE25X51I8RD4ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
89569a9d-d53e-f72d-e053-2a95a90aa9b989569a9d-d53d-f72d-e053-2a95a90aa9b92019-05-20Adverse reactionsExact identifier
spl id: 89569a9d-d53e-f72d-e053-2a95a90aa9b9
spl set id: 89569a9d-d53d-f72d-e053-2a95a90aa9b9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.